Difference between revisions of "Team:TokyoTech"

Line 17: Line 17:
  
 
<!-- Sidebar/menu -->
 
<!-- Sidebar/menu -->
−
<nav class="w3-sidebar w3-red w3-collapse w3-top w3-large w3-padding" style="z-index:3;width:300px;font-weight:bold;" id="mySidebar">
+
<nav class="w3-sidebar w3-red w3-collapse w3-top w3-large w3-padding" style="z-index:3;width:300px;font-weight:bold;" id="mySidebar"><br>
−
   <a href="javascript:void(0)" onclick="w3_close()" class="w3-button w3-hide-large w3-display-topleft" style="width:100%;font-size:22px">Close Menu</a>
+
   <a href="javascript:void(0)" onclick="w3_close()" class="w3-button w3-hide-large w3-display-topleft" style="width:100%;font-size:20px">Close Menu</a>
 
   <div class="w3-container" style="margin-top: 20px;margin-bottom: 25px">
 
   <div class="w3-container" style="margin-top: 20px;margin-bottom: 25px">
−
     <img src="https://static.igem.org/mediawiki/2017/4/40/T--TokyoTech--logo_white.png" style="width: 100%">
+
     <img src="https://static.igem.org/mediawiki/2017/a/a8/T--TokyoTech--logo_white_bright_10211603.png" style="width: 100%">
 
   </div>
 
   </div>
−
   <div class="w3-bar-block" style="padding-top: 15px">
+
   <div class="w3-bar-block" style="padding-top: 15px; padding-left: 35px">
−
     <ul id="normal" class="dropmenu">
+
 
−
     <li style="font-size: 16px; text-indent:3em">- <a href="#overview" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Home</a>  
+
  <div id="contents">
 +
     <ul id="nav" style="padding-bottom: 10px">
 +
    <li><span class="w3-bar-item w3-button w3-hover-white">
 +
     <a href="https://2017.igem.org/Team:TokyoTech">Home</a>
 +
    </span>
 +
    </li>
 +
    </ul>
 +
 
 +
    <ul id="nav" style="padding-bottom: 10px">
 +
    <li><span onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Project</span>
 +
    <ul>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Project" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Description</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Project/Proof" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Proof</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Project/Basic_Parts" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Basic Parts</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Project/Composite_Parts" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Composite Parts</a></li>
 +
    </ul>
 +
    </li>
 +
    </ul>
 +
 
 +
    <ul id="nav" style="padding-bottom: 10px">
 +
    <li><span onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Experiment</span>
 +
    <ul>
 +
      <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Overview</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI Assay</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Human_Cell_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Human Cell Assay</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment/AHK4_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">AHK4 Assay</a></li>
 +
    </ul>
 +
    </li>
 +
    </ul>
 +
 
 +
      <ul id="nav" style="padding-bottom: 10px">
 +
    <li><span onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Modelling</span>
 +
    <ul>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Model" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Overview</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Model/Model onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Model</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Model/Codes" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Codes</a></li>
 +
    </ul>
 +
    </li>
 +
    </ul>
 +
 
 +
    <ul id="nav" style="padding-bottom: 10px">
 +
    <li><span onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Human Practices</span>  
 
     <ul>
 
     <ul>
−
     <li style="font-size: 16px; text-indent:3em">- <a href="#overview" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">1</a></li>
+
     <li><a href="https://2017.igem.org/Team:TokyoTech/HP" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Overview</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/HP/Silver" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Silver</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/HP/Integrated" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Integrated Human Practice</a></li>
 +
    <li><a href="https://2017.igem.org/Team:TokyoTech/Collaborations" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Collaborations</a></li>
 
     </ul>
 
     </ul>
 
     </li>
 
     </li>
 
     </ul>
 
     </ul>
−
     <a href="#project" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Project</a>  
+
 
−
     <a href="#modeling" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Modeling</a>  
+
     <ul id="nav" style="padding-bottom: 10px">
−
     <a href="#hp" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Human Practices</a>  
+
     <li><span onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Teams</span>  
−
     <a href="#notebook" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Notebook</a>  
+
     <ul>
−
     <a href="#team" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Team</a>
+
    <li><a href="https://2017.igem.org/Team:TokyoTech/Team" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Team</a></li>
−
     <a href="#sponsers" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Sponsers</a>
+
     <li><a href="https://2017.igem.org/Team:TokyoTech/Attributions" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Attributions</a></li>
 +
     </ul>
 +
    </li>
 +
     </ul>
 +
    </div>
 +
 
 
   </div>
 
   </div>
 
</nav>
 
</nav>
Line 51: Line 100:
 
<div class="w3-main" style="margin-left:340px;margin-right:40px">
 
<div class="w3-main" style="margin-left:340px;margin-right:40px">
  
−
<div class="w3-container" id="contact" style="margin-top:30px"><!-- ページタイトル -->
+
  <div class="w3-container" id="contact" style="margin-top:30px">
−
      <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px" align="center">C8 Toxicity Assay</h2>
+
    <img src="https://static.igem.org/mediawiki/2017/2/2c/T--TokyoTech--logo10011204.jpg" alt="John" style="width:100%">
−
    </div>
+
  </div>
−
 
+
−
<hr>
+
−
 
+
  
 +
  <!-- Overview -->
 
   <div class="w3-container" id="overview" style="margin-top:20px">
 
   <div class="w3-container" id="overview" style="margin-top:20px">
−
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Introduction</b></h2>
+
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Overview</b></h1>
 
     <hr style="width:50px;border:5px solid red" class="w3-round">
 
     <hr style="width:50px;border:5px solid red" class="w3-round">
−
 
+
     <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
−
     <p style="font-size: 16px; text-indent:1em">
+
     </p>
−
    <!-- テキストはここへ -->
+
−
     </p><br>
+
−
 
+
 
   </div>
 
   </div>
  
−
<hr>
+
<img src="https://static.igem.org/mediawiki/2017/d/da/T--TokyoTech--ribbon_hr.png" alt="John" style="width:95%">
  
−
<div class="w3-container" id="overview" style="margin-top:20px">
+
 
−
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Summary of the Experiment</b></h2>
+
<!-- Project -->
 +
    <div class="w3-container" id="project" style="margin-top:20px">
 +
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Project  </b><a href="https://2017.igem.org/Team:TokyoTech/Project"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
 
     <hr style="width:50px;border:5px solid red" class="w3-round">
 
     <hr style="width:50px;border:5px solid red" class="w3-round">
 +
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
 +
    </p>
 +
  </div>
  
−
    <p style="font-size: 16px; text-indent:1em">
+
  <hr>
−
    <!-- テキストはここへ -->
+
−
    </p><br>
+
−
 
+
−
    <!-- 図開始 -->
+
−
    <div class="w3-xxxlarge" style="padding-bottom: 10px;padding-top: 10px;text-align: center">
+
−
      <figure>
+
−
      <img src="<!--画像URL-->" style="max-width:70%">
+
−
      <figcaption style="font-size: 16px">Fig. 画像タイトル</figcaption>
+
−
      </figure>
+
−
      </div><!-- 図終了 -->
+
  
 +
  <!-- Modeling -->
 +
    <div class="w3-container" id="modeling" style="margin-top:20px">
 +
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Modeling  </b><a href="https://2017.igem.org/Team:TokyoTech/Modeling"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
 +
    <hr style="width:50px;border:5px solid red" class="w3-round">
 +
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
 +
    </p>
 
   </div>
 
   </div>
  
−
<hr>
+
  <hr>
  
−
<div class="w3-container" id="overview" style="margin-top:20px">
+
  <!-- Human Practice -->
−
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Results</b></h2>
+
  <div class="w3-container" id="hp" style="margin-top:20px">
 +
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Human Practices  </b><a href="https://2017.igem.org/Team:TokyoTech/Human_Practices"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></h1>
 
     <hr style="width:50px;border:5px solid red" class="w3-round">
 
     <hr style="width:50px;border:5px solid red" class="w3-round">
 +
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
 +
    </p>
 +
  </div>
  
−
    <p style="font-size: 16px; text-indent:1em">
+
  <hr>
−
    <!-- テキストはここへ -->
+
−
    </p><br>
+
−
 
+
−
    <!-- 図開始 -->
+
−
    <div class="w3-xxxlarge" style="padding-bottom: 10px;padding-top: 10px;text-align: center">
+
−
      <figure>
+
−
      <img src="<!--画像URL-->" style="max-width:70%">
+
−
      <figcaption style="font-size: 16px">Fig. 画像タイトル</figcaption>
+
−
      </figure>
+
−
      </div><!-- 図終了 -->
+
  
 +
  <!-- Notebook -->
 +
    <div class="w3-container" id="notebook" style="margin-top:20px">
 +
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Notebook  </b><a href="https://2017.igem.org/Team:TokyoTech/Notebook"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
 +
    <hr style="width:50px;border:5px solid red" class="w3-round">
 +
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
 +
    </p>
 
   </div>
 
   </div>
  
−
   <div class="w3-container" id="overview" style="margin-top:20px">
+
   <hr>
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Materials and Methods</b></h2>
+
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
−
 
+
−
    <p style="font-size: 16px; text-indent:1em">
+
−
    <!-- テキストはここへ -->
+
−
    </p><br>
+
−
 
+
−
    <!-- 図開始 -->
+
−
    <div class="w3-xxxlarge" style="padding-bottom: 10px;padding-top: 10px;text-align: center">
+
−
      <figure>
+
−
      <img src="<!--画像URL-->" style="max-width:70%">
+
−
      <figcaption style="font-size: 16px">Fig. 画像タイトル</figcaption>
+
−
      </figure>
+
−
      </div><!-- 図終了 -->
+
  
 +
  <!-- Team -->
 +
    <div class="w3-container" id="team" style="margin-top:20px">
 +
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Team  </b><a href="https://2017.igem.org/Team:TokyoTech/Team"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
 +
    <hr style="width:50px;border:5px solid red" class="w3-round">
 +
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
 +
    </p>
 
   </div>
 
   </div>
  
−
    <div class="w3-container" id="overview" style="margin-top:20px">
+
  <hr>
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Reference</b></h2>
+
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
  
−
    <p style="font-size: 16px; text-indent:1em">
+
<!-- PAGE CONTENT! -->
−
    <!-- テキストはここへ -->
+
−
    </p><br>
+
  
 +
  <div class="w3-container" id="contact" style="margin-top:75px">
 +
    <img src="https://static.igem.org/mediawiki/2017/2/24/T-TokyoTech--coculture_system.jpg" alt="John" style="width:100%">
 
   </div>
 
   </div>
  
  
−
 
+
  <!-- Sponsers -->
−
 
+
  <div class="w3-container" id="sponsers" style="margin-top:75px;">
 +
    <h1 class="w3-xxxlarge w3-text-red" style="padding-top: 10px;padding-bottom: 10px"><b>Sponsers</b></h1>
 +
    <hr style="width:50px;border:5px solid red" class="w3-round">
 
   </div>
 
   </div>
  
 +
  <div class="w3-row-padding">
 +
    <div class="w3-col m4 w3-margin-bottom">
 +
      <div class="w3-light-grey">
 +
        <img src="https://static.igem.org/mediawiki/2016/4/47/Tokyo_Tech_JASSO.gif" style="width:100%">
 +
        <div class="w3-container">
 +
          <h3>JASSO</h3>
 +
        </div>
 +
      </div>
 +
    </div>
 +
    <div class="w3-col m4 w3-margin-bottom">
 +
      <div class="w3-light-grey">
 +
        <img src="http://kuramae-old.tokyo.r-cms.jp/files/user/common/p_images/head_logo.gif" style="width:100%">
 +
        <div class="w3-container">
 +
          <h3>Kuramae Kougyoukai</h3>
 +
        </div>
 +
      </div>
 +
    </div>
 +
    <div class="w3-col m4 w3-margin-bottom">
 +
      <div class="w3-light-grey">
 +
        <img src="http://www.vmcs.ucdavis.edu/idt/images/idt-logo.jpg" style="width:100%">
 +
        <div class="w3-container">
 +
          <h3>IDT</h3>
 +
        </div>
 +
      </div>
 +
    </div>
 +
  </div>
  
 
<!-- End page content -->
 
<!-- End page content -->
Line 146: Line 209:
  
 
<!-- W3.CSS Container -->
 
<!-- W3.CSS Container -->
−
<div class="w3-light-grey w3-container w3-padding-32" style="margin-top:75px;padding-right:58px"><p class="w3-right">Hajime Fujita:  <a href="96haji.me" title="W3.CSS" target="_blank" class="w3-hover-opacity">All Rights Reserved</a></p><br></div>
+
<div class="w3-light-grey w3-container w3-padding-32" style="margin-top:75px;padding-right:58px"><p class="w3-right">Hajime Fujita:  <a href="96haji.me" title="W3.CSS" target="_blank" class="w3-hover-opacity">All Rights Reserved</a></p></div>
  
 
<script>
 
<script>

Revision as of 00:33, 30 October 2017

<!DOCTYPE html> Coli Sapiens

iGEM Tokyo Tech
John

Overview

Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.

John

Project

Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.

Modeling

Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.

Notebook

Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.

Team

Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.

John

Sponsers

JASSO

Kuramae Kougyoukai

IDT

Hajime Fujita: All Rights Reserved